Sevelamer improves hepatic steatosis and modulates inflammation in a Western Diet mouse model of non-alcoholic fatty liver disease (NAFLD)

被引：0

作者：

McGettigan, Brett ^{[1
]}

McMahan, Rachel ^{[1
]}

Porsche, Cara ^{[1
]}

Orlicky, David J. ^{[1
]}

Wang, Xiaoxin ^{[1
]}

Luo, Yuhuan ^{[1
]}

Levi, Moshe ^{[1
]}

Rosen, Hugo R. ^{[1
,2
]}

机构：

[1] Univ Colorado, Aurora, CO USA

[2] Natl Jewish Med Ctr, Denver, CO USA

来源：

HEPATOLOGY | 2014年 / 60卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1125

引用

页码：746A / 747A

页数：2

共 50 条

[1] LPSF/GQ-02 Inhibits the Development of Hepatic Steatosis and Inflammation in a Mouse Model of Non-Alcoholic Fatty Liver Disease (NAFLD)
Soares e Silva, Amanda Karolina
Cipriano Torres, Dilenia de Oliveira
dos Santos Gomes, Fabiana Oliveira
Silva, Bruna dos Santos
Ribeiro, Edlene Lima
Oliveira, Amanda Costa
Martins dos Santos, Laise Aline
Alves de Lima, Maria do Carmo
Pitta, Ivan da Rocha
Peixoto, Christina Alves
PLOS ONE, 2015, 10 (04):
[2] Adipokines and Endotoxemia Correlate with Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease (NAFLD)
Nier, Anika
Huber, Yvonne
Labenz, Christian
Michel, Maurice
Bergheim, Ina
Schattenberg, Joern M.
NUTRIENTS, 2020, 12 (03)
[3] Biomarkers identifying hepatic inflammation in non-alcoholic fatty liver disease (NAFLD)
Werge, Mikkel
Hoegl, Annabelle
Therkelsen, Marie Louise
Gronborg, Mads
Mazzoni, Gianluca
Harder, Lea Morch
Hvid, Henning
Rashu, Elias
Thing, Mira
Hetland, Liv
Junker, Anders
Serizawa, Reza
Vyberg, Mogens
Galsgaard, Elisabeth
Gluud, Lise Lotte
JOURNAL OF HEPATOLOGY, 2023, 78 : S742 - S743
[4] The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease
Ryan, Marno C.
Itsiopoulos, Catherine
Thodis, Tania
Ward, Glenn
Trost, Nicholas
Hofferberth, Sophie
O'Dea, Kerin
Desmond, Paul V.
Johnson, Nathan A.
Wilson, Andrew M.
JOURNAL OF HEPATOLOGY, 2013, 59 (01) : 138 - 143
[5] HEPATOCYTE SENESCENCE EXACERBATES HEPATIC STEATOSIS AND CYTOKINE SECRETOME IN A WESTERN DIET-FED MURINE MODEL OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
Kundu, Debjyoti
Kennedy, Lindsey
Meadows, Vik
Chen, Lixian
Zhou, Tianhao
Kyritsi, Konstantina
Wu, Nan
Ceci, Ludovica
Ekser, Burcin
Alpini, Gianfranco
Francis, Heather L.
HEPATOLOGY, 2021, 74 : 1068A - 1068A
[6] Regulation of Hepatic Inflammation by Folic Acid in Non-alcoholic Fatty Liver Disease (NAFLD)
Sid, Victoria
Shang, Yvette
Siow, Chris
Karmin, O.
FASEB JOURNAL, 2017, 31
[7] Maraviroc, a CCR5 antagonist, prevents the development of hepatic steatosis in a mouse model of non-alcoholic fatty liver disease (NAFLD)
Perez-Martinez, L.
Perez-Matute, P.
Aguilera-Lizarraga, J.
Rubio, S.
Narro, J.
Ochoa-Callejero, L.
Oteo, J. A.
Blanco, J. R.
ANTIVIRAL THERAPY, 2013, 18 : A69 - A69
[8] Maraviroc, a CCR5 antagonist, ameliorates the development of hepatic steatosis in a mouse model of non-alcoholic fatty liver disease (NAFLD)
Perez-Martinez, Laura
Perez-Matute, Patricia
Aguilera-Lizarraga, Javier
Rubio-Mediavilla, Susana
Narro, Judit
Recio, Emma
Ochoa-Callejero, Laura
Oteo, Jose-Antonio
Blanco, Jose-Ramon
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (07) : 1903 - 1910
[9] Changes in the gut microbiota caused by ASBTi suppress intrahepatic steatosis and inflammation in a mouse model of non-alcoholic fatty liver disease (NAFLD)
Matsui, Masahiro
Asai, Akira
Okamoto, Norio
Nishikawa, Tomohiro
Ohama, Hideko
Tsuchimoto, Yusuke
Fukunishi, Shinya
Higuchi, Kazuhide
JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
[10] Losartan Improves Hepatic Inflammation in Children With Non-Alcoholic Fatty Liver Disease
Vos, Miriam
Jin, Ran
Welsh, Jean
Konomi, Juna
Karpen, Saul J.
Soler-Rodriquez, Dellys
Cleeton, Rebecca L.
Jones, Dean
GASTROENTEROLOGY, 2016, 150 (04) : S1036 - S1036

← 1 2 3 4 5 →